Cleared Traditional

K850902 - DATA ZYME ACID PHOSPHATASE PROCEDURE

K850902 is the FDA 510(k) clearance for DATA ZYME ACID PHOSPHATASE PROCEDURE by Data Medical Associates, Inc.. It is a Class 2 Chemistry device (product code CKB) cleared through the Traditional 510(k) pathway after a 15-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1985
Decision
15d
Days
Class 2
Risk

K850902 is an FDA 510(k) clearance for the DATA ZYME ACID PHOSPHATASE PROCEDURE. Classified as Acid Phosphatase, Naphthyl Phosphate (product code CKB), Class II - Special Controls.

Submitted by Data Medical Associates, Inc. (Arlington, US). The FDA issued a Cleared decision on March 20, 1985 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1020 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Data Medical Associates, Inc. devices

Submission Details

510(k) Number K850902 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 1985
Decision Date March 20, 1985
Days to Decision 15 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 88d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CKB Acid Phosphatase, Naphthyl Phosphate
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1020
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CKB Acid Phosphatase, Naphthyl Phosphate

All 16
Devices cleared under the same product code (CKB) and FDA review panel - the closest regulatory comparables to K850902.
ACID PHOSPHATASE (KINETIC) CAT. # 320-06
K875209 · Diagnostic Chemicals, Ltd. (Usa) · Feb 1988
ACID PHOSPHATASE (ACP) REAGENT
K863851 · Sigma Diagnostics, Inc. · Oct 1986
ACID PHOSPHATASE PROCEDURE
K861675 · Data Medical Associates, Inc. · May 1986
PARAMAX ACID PHOSPHATASE REAGENT
K840661 · American Dade · Apr 1984
RAICHEM ACID PHASPHATASE REAGENT
K831834 · Reagents Applications, Inc. · Aug 1983
BOEHRINGER MANNEHEIM DIAG. ACID PHOSPHA
K823087 · Boehringer Mannheim Corp. · Nov 1982